Pharma's social status: LinkedIn and FB up, Twitter down, Instagram finally appears

.

Facebook is the go-to platform for pharma marketers. In a new study, 73% of pharma marketing teams say they plan to use the platform during the next two years, an 8-percentage-point increase since Cutting Edge Information's previous survey in 2013.

Ver:

JANSEN: Giro de 360º y "tira la toalla"...en el "feis".

That's not surprising, considering Facebook’s mainstream ubiquity and large reach, along with stepped-up efforts by Facebook to reach out to the pharma industry. What might be surprising, however, is how much other social platforms have gained—or lost—in the world of drug marketing. Twitter took a big fall below the 50% mark, while LinkedIn soared upward in its place. Pinterest? Gone. Instagram? Finally popped up. 

LinkedIn made the biggest gain in projected use since the last survey. The business-friendly social networking site grew by 29 percentage points. Just 26% of pharma marketers planned to use it in 2013; this year, that grew to 55%. 

Ver:

Linkedin en su laberinto...

Not nearly as important anymore was 140-character Twitter, where projected usage among pharma marketers dropped 19 percentage points. Only 45% plan to use it now, down from 64% in 2013. 

Among the smaller social media platforms, Tumblr was on the to-do list for 9% of pharma marketers, while Instagram showed up for the first time in the survey, with 18% saying they’ll use it in the coming two years, said Natalie DeMasi, research team leader at Cutting Edge Information. Gone this year was Pinterest—which got zero reports of planned use, same as Vine, Flickr and Reddit.

 (...) 

Challenges still remain in digital marketing as pharma gets up to speed on technology but continues to deal with some audiences—some old-school doctors, for instance—who don’t want tech solutions. 

 “Today pharma marketers have to do a lot of research ahead of time to figure out what will speak most to their target audiences. Sometimes, the best thing to do might not be using the new technology. But other times you have to go all the way. Do the research to find out,” DeMasi said. (Más)